Pharma News

Sandoz, a Novartis division and the global leader in biosimilars, today announced a global partnership with Asia's premier biopharmaceuticals company, Biocon, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide. [...]
Thu, Jan 18, 2018
Source Pharma News
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs. This discovery, led by researchers at the University of Cambridge, was aided by Eve, an artificially-intelligent 'robot scientist'. [...]
Thu, Jan 18, 2018
Source Pharma News
Many drugs work by inhibiting protein enzymes associated with a particular disease. Unfortunately, the same drugs can inhibit protein enzymes unrelated to the disease, resulting in harmful side effects. One potential solution is to better identify structural features that determine a protein enzyme's function. [...]
Wed, Jan 17, 2018
Source Pharma News
A report from the U.S. Food and Drug Administration (FDA) published in Pharmacoepidemiology & Drug Safety confirms the safety profile and effectiveness of Xarelto® (rivaroxaban) in people with atrial fibrillation (AF). The study is based on electronic healthcare data within the Mini-Sentinel safety programme in the US, reporting data on [...]
Tue, Jan 16, 2018
Source Pharma News

(by Worldpharmanews)

Contact us
Dispopharm D&P Ltd.
Gewerbestrasse 18
4123 Allschwil
Phone: +41 61 487 96 36
Fax. +41 61 487 96 20
No dates at the moment.